Cite
HARVARD Citation
Agarwal, K. et al. (2023). Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study. Journal of viral hepatitis. 30 (3), pp. 209-222. [Online].